Using machine learning technology, a new study has identified three distinct profiles describing social and economic factors that are associated with a higher risk of suicide.
At a multinational pharmaceutical company, employees who were nominated for, but not awarded, top performance ratings were at least 34% more likely to leave voluntarily.
The Varian Edge linear accelerator provides state-of-the art, non-invasive radiotherapy treatments. The closest comparable facilities are in New York City, and while approximately 40% of veterinary schools have radiation oncology programs, few have access to such technology. Cornell’s Varian Edge replaces machinery previously installed in 2000.
The Weill Institute for Cell and Molecular Biology at Cornell has selected eight outstanding graduate and post-doctoral students as recipients of this year’s Weill Institute Emerging Scholars Award.
The Weill Institute for Cell and Molecular Biology will bring together leading scientists from across the globe and across disciplines for its 8th Biennial Weill Institute Symposium, Oct. 13–14. The two-day program, taking place in Ithaca, NY., will showcase advances in molecular and cell biology research, while fostering opportunities for Cornell students and postdoctoral scholars to connect with internationally recognized leaders in the life sciences.
The new Startup Cornell podcast episode features Van Hamilton Barbeau '11, MS/MBA '20, AVP at Ochsner Ventures, the venture capital arm of Ochsner Health.
Margaret Rossiter, the Marie Underhill Noll Emerita Professor of the History of Science in the College of Arts and Sciences (A&S) and known worldwide for her studies of the history of women in science, died Aug. 3. She was 81.
Cornell researchers partner with EDF and industry to study mitigation strategies that could minimize hydrogen emissions and maximize the climate benefit of a growing hydrogen economy.